PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 4, 2026SHILAP Revista de lepidopterología0 citationsOpen Access

Development and validation of a nomogram predicting osteoporosis risk in rheumatoid arthritis

LWLujing WangYGYe GuXZXi Zhang

Key Points

  • The aim is to develop and validate a nomogram that predicts the risk of osteoporosis in patients with rheumatoid arthritis.
  • Single-center retrospective study of 349 RA patients using DXA data.
  • Divided into a training cohort of 250 and a validation cohort of 99.
  • Stepwise backward logistic regression identified independent predictors included in the nomogram.
  • Nomogram demonstrated AUROC of 0.812 in training and 0.788 in validation.
  • Good calibration with a Hosmer–Lemeshow p-value > 0.05.
  • Significant odds ratios for medium and high risk strata in the nomogram.

Abstract

Background Rheumatoid arthritis (RA) increases the risk of osteoporosis, but tools that integrate RA-specific clinical and metabolic factors to predict osteoporosis risk are limited. We aimed to develop and validate a practical risk prediction nomogram for osteoporosis in RA patients. Methods In this single-center retrospective study, 349 RA patients with available DXA data were analyzed; 132 (37.8%) had osteoporosis. A training cohort ( n = 250; osteoporosis = 92) and a temporal validation cohort ( n = 99; osteoporosis = 40, enrolled later in the study period) were used. Candidate predictors included clinical, functional, and laboratory variables. Stepwise backward logistic regression identified independent predictors that were incorporated into a nomogram. Model performance was assessed by discrimination (AUROC), calibration (calibration curve and Hosmer–Lemeshow test), decision curve analysis (DCA), and risk stratification. Results Female sex, higher health assessment questionnaire-disability index (HAQ-DI), elevated alkaline phosphatase (ALP), increased ApoA1/ApoB ratio, higher free fatty acids (FFA), and lower body mass index (BMI) were independent predictors of osteoporosis and were included in the nomogram. The model yielded AUROCs of 0.812 (training) and 0.788 (validation), showed good calibration (Hosmer–Lemeshow p 0.05), and provided positive net benefit across a range of threshold probabilities in DCA. Nomogram-based risk strata (low/medium/high) discriminated osteoporosis risk with statistically significant odds ratios for medium and high groups. Conclusion The proposed nomogram, built from readily available clinical and laboratory measures, demonstrates good discrimination, calibration, and clinical utility for identifying RA patients at elevated risk of osteoporosis, and may facilitate targeted screening and early intervention. However, the model’s performance in diverse populations remains unknown, and prospective multicenter external validation is essential before any clinical application.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/69f836aa3ed186a739980e7fhttps://doi.org/10.3389/fmed.2026.1747090
Ask AI
Helpful
Bookmark
Share
View Full Paper